𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Extracorporeal photopheresis: How, when, and why

✍ Scribed by David M. Ward

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
686 KB
Volume
26
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Extracorporeal photopheresis (ECP) is a well‐tolerated procedure that suppresses T‐lymphocyte activity in a clonally‐specific way. It is an effective therapy that has established indications in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and some scenarios of solid‐organ transplant rejection. It is being used increasingly around the world. Its applications are evolving, including exploration of its potential for treating autoimmune diseases where cytotoxic T‐cell‐mediated mechanisms appear to be involved, such as Crohn's disease. This article reviews scientific insights into its mechanism of action on the immune system, details of the clinical procedure, its clinical applications in various diseases, and the current evidence for its efficacy and place in medical therapeutics. J. Clin. Apheresis, 2011. © 2011 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

I02 GVHD and extracorporeal photopheresi
I02 GVHD and extracorporeal photopheresis
✍ H.T. Greinix 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Graft-versus-host disease (GVHD) is a major cause of mortality after allogeneic hematopoietic stem cell transplantation (HSCT). Extracorporeal exposure of peripheral blood mononuclear cells to the photosensitizing agent 8-methoxypsoralen and ultraviolet A radiation has been shown to be effective in

In vivo EPR: When, How and Why?
In vivo EPR: When, How and Why?
✍ Bernard Gallez; Harold M. Swartz 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 8 KB 👁 1 views
‘DO NOT RESUSCITATE’: HOW? WHY? AND WHEN
‘DO NOT RESUSCITATE’: HOW? WHY? AND WHEN?
✍ URSULA SKERRITT; BRICE PITT 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

Objective. The main objective was to discover who had `Do Not Resuscitate' (DNR) status, why, how, when and by whom these decisions were made. Design, setting and patients. The medical and nursing notes of all inpatients (139) (age range 16±100 years) in an inner city district general hospital on a

In vivo EPR: when, how and why?
In vivo EPR: when, how and why?
✍ Bernard Gallez; Harold M. Swartz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB